EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ferrostatin-1 post-treatment attenuates acute kidney injury in mice by inhibiting ferritin production and regulating iron uptake-related proteins

Yanxiu Zhao, Binhua Jiang, Dinghui Huang, Juxiang Lou, Guoshun Li, Jianqi Liu, Fuhui Duan, Yuan Yuan, Xiaoyan Su

PeerJ · 2023

DOI: 10.7717/peerj.15786 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2023. Verfasst von Yanxiu Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Baoshan People's Hospital, Baoshan, People's Republic of China. Hauptthemen laut MEDLINE: Ferritins, Acute Kidney Injury. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute kidney injury (AKI) is a common and serious medical condition with high morbidity and mortality. Recent research has highlighted ferroptosis, a novel form of programmed cell death, as a potential therapeutic target in mitigating renal tubular injury in AKI. Ferrostatin-1, a specific ferroptosis inhibitor, has been demonstrated to prevent renal injury through ferroptosis inhibition.

Methods

Utilizing a murine AKI model, we investigated the effects of Ferrostatin-1 by administering it post-injury. Through high-throughput sequencing and pathological analysis, we focused on the critical role of ferroptosis-related pathways in the treatment.

Results

Ferrostatin-1 post-conditioning effectively mitigated oxidative damage and reduced iron content associated with AKI. Additionally, critical ferroptosis-related proteins, such as GPX4, SLC7A11, NRF2, and FTH1, exhibited increased expression levels. In vitro , Ferrostatin-1 treatment of HK-2 cells significantly diminished lipid peroxidation and iron accumulation. Furthermore, Ferrostatin-1 was found to downregulate the PI3K signalling pathway.

Conclusion

Ferrostatin-1 acted as a potential ferroptosis inhibitor with the capacity to enhance antioxidant defences. This study suggests that Ferrostatin-1 could serve as a promising novel strategy for improving the treatment of AKI and promoting recovery from the condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerritinsAcute Kidney InjuryAnimalsMiceIronCyclohexylaminesPhenylenediamines

Stichwörter der Autor:innen

Acute kidney injuryFerrostatin-1Iron death

Substanzen

FerritinsIronCyclohexylaminesferrostatin-1Phenylenediamines

Autor:innen und Institutionen

  • Department of Nephrology, Baoshan People's Hospital, Baoshan, People's Republic of China.
  • Department of Obstetrics, Baoshan People's Hospital, Baoshan, People's Republic of China.
  • Department of Pediatrics, Baoshan People's Hospital, Baoshan, People's Republic of China.
  • Intensive Care Unit, Ningbo Medical Center Lihuili Hospital, Ningbo, People's Republic of China.

Zitieren

APA

Zhao, Y., Jiang, B., Huang, D., Lou, J., Li, G., Liu, J., Duan, F., Yuan, Y., & Su, X. (2023). Ferrostatin-1 post-treatment attenuates acute kidney injury in mice by inhibiting ferritin production and regulating iron uptake-related proteins. PeerJ. https://doi.org/10.7717/peerj.15786

Vancouver

Zhao Y, Jiang B, Huang D, Lou J, Li G, Liu J, et al. Ferrostatin-1 post-treatment attenuates acute kidney injury in mice by inhibiting ferritin production and regulating iron uptake-related proteins. PeerJ. 2023. doi:10.7717/peerj.15786

BibTeX
@article{Zhao2023,
  author = {Zhao, Yanxiu and Jiang, Binhua and Huang, Dinghui and Lou, Juxiang and Li, Guoshun and Liu, Jianqi and Duan, Fuhui and Yuan, Yuan and Su, Xiaoyan},
  title = {Ferrostatin-1 post-treatment attenuates acute kidney injury in mice by inhibiting ferritin production and regulating iron uptake-related proteins},
  journal = {PeerJ},
  year = {2023},
  doi = {10.7717/peerj.15786}
}
Kostenlos starten →